Ketorolac Tromethamine Injection, Solution
Product Images NDC 25021-701

4 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 25021-701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ket06 0001 01)

Structural Formula (Ket06 0001 01)
Chemical structure of ketorolac tromethamine, showing ketorolac molecule and tromethamine molecule as separate components represented with molecular formulas C15H13NO3 and C4H11NO3 respectively.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ket06 0002 02)

Package Label – Principal Display Panel – Vial Label (Ket06 0002 02)
Label for Ketorolac Tromethamine injection, USP, 15 mg per mL strength in a 1 mL single-dose vial. This human prescription drug is indicated for intravenous or intramuscular use. Manufactured for Sagent Pharmaceuticals, Schaumburg, Illinois, USA, with manufacturing done in India. The label includes storage instructions to protect from light and displays the NDC number 25021-700-01.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ket06 0002 03)

Package Label – Principal Display Panel – Vial Label (Ket06 0002 03)
Label for Ketorolac Tromethamine Injection USP 30 mg per mL in a 1 mL single-dose vial. The label indicates use for intravenous or intramuscular administration. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, and made in India. Label includes NDC 25021-701-01 and barcode.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ket06 0002 04)

Package Label – Principal Display Panel – Vial Label (Ket06 0002 04)
Label for Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL) in a 2 mL single-dose vial. The label indicates intramuscular use only and advises protection from light. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, by a facility in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.